Clinical Trials Directory

Trials / Sponsors / CellSight Technologies, Inc.

CellSight Technologies, Inc.

Industry · 10 registered clinical trials — 4 currently recruiting.

StatusTrialPhaseStarted
RecruitingImaging Advanced NSCLC Patients Undergoing PD-1/PD-L1 Directed Therapy Using [18F]-FARAG
Advanced Non Small Cell Lung Cancer
Phase 22023-11-01
RecruitingTest-retest Evaluation of [18F]F-AraG PET
Non-small Cell Lung Cancer
Phase 22023-10-31
TerminatedA Study Using [18F]F AraG PET to Evaluate Response to Checkpoint Inhibitor Therapy(CkIT) in Patients With Soli
Correlate Tracer Uptake to TCell Tumor Infiltration & CkIT Benefit
Phase 22022-03-01
UnknownImaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
Non Small Cell Lung Cancer
Phase 22021-04-15
RecruitingImaging Immune Activation in COVID-19
Covid19, SARS-CoV Infection
Phase 22021-04-15
RecruitingImaging Immune Activation in HIV by PET-MR
HIV Infections
Phase 22018-09-21
CompletedDetection of Graft Versus Host Disease With [18F]F-AraG
Graft Versus Host Disease
Phase 12018-05-15
CompletedStudy to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (S
Squamous Cell Carcinoma of the Head and Neck
Phase 12017-05-01
Unknown[18F]FAraG PET Imaging for Analysis of Biodistribution in Cancer Patients Expected to Undergo Immunotherapy an
Cancer
Phase 12017-05-01
CompletedStudy of Kinetics, Dosimetry & Safety of [18F]F-AraG, a Positron Emission Tomography Imaging Tracer in Healthy
Cancer
Phase 12015-02-01